Biotechnology And Pharmaceutical Services Outsourcing Analysis Report 2026: $101.56 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, And Forecasts, 2020-2025, 2025-2030F, 2035F

(MENAFN- GlobeNewsWire - Nasdaq) The biotechnology and pharmaceutical services outsourcing market is set to capitalize on the increasing complexity of drug pipelines, demand for specialized expertise, and growth in clinical research. Opportunities lie in expanding AI-driven drug discovery, flexible partnerships, and end-to-end lifecycle management, particularly in emerging markets.

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Biotechnology and Pharmaceutical Services Outsourcing Market Report 2026" has been added to ResearchAndMarkets's offering.

The biotechnology and pharmaceutical services outsourcing market is poised for robust growth, expanding from $71.87 billion in 2025 to $77.21 billion in 2026, with a CAGR of 7.4%. This upward trajectory is driven by increasing drug complexity, regulatory scrutiny, expansion of clinical trials, biotech startups, and the need for specialized expertise. By 2030, the market is expected to reach $101.56 billion, propelled by biologics and cell therapy development, flexible outsourcing demands, AI in drug discovery, emerging market manufacturing, and speed-to-market strategies.

The market research report offers comprehensive insight into the biotechnology and pharmaceutical services outsourcing industry, covering global market size, regional shares, market trends, and opportunities, alongside a detailed analysis of current and future industry scenarios. The market's revenue includes pharmacovigilance, medical writing, data management, analytical testing services, and formulation development. Revenue calculation reflects the total value of goods and services offered within the market, focusing on direct consumer and entity transactions.

Key trends include the outsourcing of specialized drug services, regulatory support demand, data-driven R&D models, and lifecycle management services. The intensification of clinical research, necessary for developing new therapies to combat chronic diseases, plays a crucial role in market growth. Outsourcing supports efficient, cost-effective trials globally, highlighted by a 15% increase in UK clinical trial recruitment reported by the ABPI in 2023.

Leading market companies are innovating with cloud-based platforms for real-time collaboration and remote access. Charles River Labs launched Apollo in 2023, a cloud platform to enhance toxicology studies, offering clients extensive study data access and self-service tools for progress monitoring and budget planning. IntegriChain's 2024 acquisition of Federal Compliance Solutions aims to bolster commercialization and revenue operations management capabilities.

Prominent companies in this sector include Thermo Fisher Scientific Inc, LabCorp Holdings, IQVIA Inc, ICON Plc, Eurofins Scientific SE, Lonza Group Ltd, Syneos Health, Catalent Inc, Charles River Laboratories, Samsung Biologics Co Ltd, WuXi Biologics, Recipharm AB, Medpace Holdings Inc, and others.

North America dominated the market in 2025, but Asia-Pacific is expected to be the fastest-growing region. The market spans regions such as Asia-Pacific, Europe, North and South America, Africa, and major countries including the USA, UK, China, and India.

Outsourcing in this field allows life sciences companies to focus on core competencies while enhancing efficiency and reducing costs through external expertise and resources. Core services include consulting, regulatory affairs, product development, auditing, and training, utilized across various therapeutic areas and by pharmaceutical companies, biotech firms, and research institutions.

Key Attributes:

Report Attribute	Details
No. of Pages	250
Forecast Period	2026 - 2030
Estimated Market Value (USD) in 2026	$77.21 Billion
Forecasted Market Value (USD) by 2030	$101.56 Billion
Compound Annual Growth Rate	7.1%
Regions Covered	Global

Major Trends

• Increasing Outsourcing of Specialized Drug Development Services
• Rising Demand for Regulatory and Compliance Support
• Growing Adoption of Data-Driven R&D Outsourcing Models
• Expansion of End-to-End Lifecycle Management Services
• Enhanced Focus on Cost and Time Optimization

Companies Featured

• Thermo Fisher Scientific Inc
• LabCorp Holdings
• IQVIA Inc
• ICON Plc
• Eurofins Scientific SE
• Lonza Group Ltd
• Syneos Health
• Catalent Inc
• Charles River Laboratories
• Samsung Biologics Co Ltd
• WuXi Biologics
• Recipharm AB
• Medpace Holdings Inc
• Curia Inc
• CordenPharma Corp
• Parexel International Ltd
• Lachman Consultants
• Concept Heidelberg GmbH
• The Quantic Group Ltd
• PRA Health Sciences
• PPD Inc
• Covance Inc
• Alcami Corporation
• Pharmalex GmbH

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Biotechnology and Pharmaceutical Services Outsourcing Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN11052026004107003653ID1111097665